Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Journal Information
Full Title: Diabetol Metab Syndr
Abbreviation: Diabetol Metab Syndr
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Endocrinology & Metabolism
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThis study does not involve human participants. There is no patient involved in this study. Competing interestsThe authors have no conflicts of interest to declare. Competing interests The authors have no conflicts of interest to declare."
"Funding The present research was supported by Exploring the clinical efficacy and related mechanisms of Sancai Lianmei Granule for early remission of type 2 diabetes Based on the combination of traditional Chinese medicine and high-throughput sequencing technology (2023zd020). The design of this review was done without the involvement of any funders or sponsors."
"The protocol for this meta-analysis has been registered on Prospero, the international prospective register of systematic reviews, under the identifier CRD42022355940 (https://www.crd.york.ac.uk/prospero/#myprospero). We adhered to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines for conducting, reporting and updating the systematic review and meta-analysis (Additional file : Table S1) []."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025